Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers
by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off
Updated on: May 09,2024
4
Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers
by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off
Updated on:May 09,2024
4